HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
5.75
+0.05 (+0.88%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close5.70
Open5.70
Bid5.20 x 500
Ask6.40 x 500
Day's Range5.65 - 5.80
52 Week Range2.30 - 6.05
Volume86,192
Avg. Volume176,758
Market Cap204.719M
Beta1.05
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Can The Uptrend Continue for Harvard Bioscience (HBIO)?
    Zacks9 days ago

    Can The Uptrend Continue for Harvard Bioscience (HBIO)?

    Investors certainly have to be happy with Harvard Bioscience, Inc. (HBIO) and its short term performance

  • 4 Top-Ranked Tech Stocks Under $20 With Room to Run
    InvestorPlacelast month

    4 Top-Ranked Tech Stocks Under $20 With Room to Run

    There are other stocks too outside these household names with a good Zacks Rank that are also great growth stocks. Which Tech Stocks to Pick? To cash in on the favorable technology trends, this is the right time to add a few technology stocks that have growth potential.

  • 4 Top-Ranked Tech Stocks Under $20 With Room to Run
    Zackslast month

    4 Top-Ranked Tech Stocks Under $20 With Room to Run

    Technology stocks like Harvard Bioscience (HBIO) and TechTarget, Inc. (TTGT), among others, have great growth potential.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of HBIO earnings conference call or presentation 1-Mar-18 9:30pm GMT

    Q4 2017 Harvard Bioscience Inc Earnings Call

  • Associated Press2 months ago

    Harvard Bioscience posts 4Q profit

    The Holliston, Massachusetts-based company said it had profit of 3 cents per share. Earnings, adjusted for one-time gains and costs, came to 5 cents per share. The medical instruments maker posted revenue ...

  • An Intrinsic Value Calculation For Harvard Bioscience Inc (NASDAQ:HBIO) Shows Investors Are Overpaying
    Simply Wall St.2 months ago

    An Intrinsic Value Calculation For Harvard Bioscience Inc (NASDAQ:HBIO) Shows Investors Are Overpaying

    I am going to run you through how I calculated the intrinsic value of Harvard Bioscience Inc (NASDAQ:HBIO) using the discounted cash flow (DCF) method. Anyone interested in learning aRead More...

  • American City Business Journals3 months ago

    Harvard Bioscience snaps up lab equipment firm for $70M

    Harvard Bioscience, a Holliston company that makes life sciences equipment, has agreed to acquire a Minnesota-based firm that makes implantable devices for monitoring blood glucose levels in lab animals. Under the deal, which was announced on Monday and is expected to close by early next month, Harvard Bioscience (HBIO) said it would pay $70 million to buy Data Sciences International. The privately held, 180-employee company makes so-called “telemetry” systems that allow researchers to measure the glucose levels of mice and rats in real time.

  • American City Business Journals3 months ago

    Twin Cities lab animal monitoring company to be sold for $70M

    Data Sciences International, which makes equipment for monitoring lab animals, has reached a deal to be sold to a Massachusetts company for about $70 million. The buyer is Harvard Bioscience, a Holliston, Mass.-based company that makes life sciences equipment. St. Paul-based Data Sciences International has about 180 employees and generated roughly $44 million in revenue last year.

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of HBIO earnings conference call or presentation 26-Oct-17 8:30pm GMT

    Q3 2017 Harvard Bioscience Inc Earnings Call

  • Associated Press6 months ago

    Harvard Bioscience reports 3Q loss

    On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 1 cent. Earnings, adjusted for stock option expense and amortization costs, came to 3 cents per share. The medical ...

  • Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
    Capital Cube6 months ago

    Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Harvard Bioscience, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Harvard Bioscience, Inc. – Agilent Technologies, Inc. (A-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 25.21 million, Net Earnings of USD -0.38 ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of HBIO earnings conference call or presentation 27-Jul-17 8:30pm GMT

    Q2 2017 Harvard Bioscience Inc Earnings Call

  • Associated Press9 months ago

    Harvard Bioscience reports 2Q loss

    The Holliston, Massachusetts-based company said it had a loss of 1 cent per share. Earnings, adjusted for stock option expense and amortization costs, were 3 cents per share. The medical instruments maker ...

  • Capital Cube10 months ago

    ETFs with exposure to Harvard Bioscience, Inc. : July 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Harvard Bioscience, Inc. Here are 5 ETFs with the largest exposure to HBIO-US. Comparing the performance and risk of Harvard Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube10 months ago

    ETFs with exposure to Harvard Bioscience, Inc. : June 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Harvard Bioscience, Inc. Here are 5 ETFs with the largest exposure to HBIO-US. Comparing the performance and risk of Harvard Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube11 months ago

    Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Harvard Bioscience, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Harvard Bioscience, Inc. – PerkinElmer, Inc., Bruker Corporation, Thermo Fisher Scientific Inc., Johnson & Johnson, Becton, Dickinson and Company, Danaher Corporation, General Electric Company and Bio-Rad Laboratories, Inc. ... Read more (Read more...)

  • Thomson Reuters StreetEventslast year

    Edited Transcript of HBIO earnings conference call or presentation 27-Apr-17 8:30pm GMT

    Q1 2017 Harvard Bioscience Inc Earnings Call

  • Associated Presslast year

    Harvard Bioscience reports 1Q loss

    On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 3 cents. Earnings, adjusted for stock option expense and amortization costs, were 2 cents per share. The medical instruments ...